Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
Although further studies are needed to improve our understanding of seronegative NMOSD, our findings underscore the importance of aggressive treatment with high-efficacy immunotherapies in both NMOSD subtypes, regardless of serostatus.
Authors
- Sifat Sharmin (ORCID: https://orcid.org/0000-0001-7294-9723)
- José Luis Sánchez-Menoyo (ORCID: https://orcid.org/0000-0003-2634-8294)
- Guy Laureys (ORCID: https://orcid.org/0000-0002-1708-4373)
- Yi Chao Foong (ORCID: https://orcid.org/0000-0001-6447-078X)
- Tomáš Kalinčík (ORCID: https://orcid.org/0000-0003-3778-1376)
- Helmut Butzkueven (ORCID: https://orcid.org/0000-0003-3940-8727)
- Mastura Monif (ORCID: https://orcid.org/0000-0001-6404-9768)
- Anneke van der Walt (ORCID: https://orcid.org/0000-0002-4278-7003)
- Saif Huda (ORCID: https://orcid.org/0000-0003-0980-3750)
- Raed Alroughani (ORCID: https://orcid.org/0000-0001-5436-5804)
- Pamela McCombe (ORCID: https://orcid.org/0000-0003-2704-8517)
- Petra Nytrová (ORCID: https://orcid.org/0000-0003-4885-602X)
- Wei Zhen Yeh (ORCID: https://orcid.org/0000-0002-5335-6612)
- Samia Joseph Khoury (ORCID: https://orcid.org/0000-0003-3198-6063)
- Matteo Foschi (ORCID: https://orcid.org/0000-0002-0321-7155)
- Aysun Soysal (ORCID: https://orcid.org/0000-0002-1598-5944)
- Recai Türkoğlu (ORCID: https://orcid.org/0000-0001-9724-851X)
- Barbara Willekens (ORCID: https://orcid.org/0000-0002-5212-8837)
- Francesco Patti (ORCID: https://orcid.org/0000-0002-6923-0846)
- Abdullah Rashid Al-Asmi (ORCID: https://orcid.org/0000-0002-2851-8157)
- Pakeeran Siriratnam (ORCID: https://orcid.org/0000-0003-4751-2102)
- Ayşe Altıntaş (ORCID: https://orcid.org/0000-0002-8524-5087)
- Paul G. Sanfilippo (ORCID: https://orcid.org/0000-0002-1778-9154)
- Tünde Csépány (ORCID: https://orcid.org/0000-0002-8305-3209)
- Vilija Jokubaitis (ORCID: https://orcid.org/0000-0002-3942-4340)
- Serkan Özakbaş (ORCID: https://orcid.org/0000-0003-2140-4103)
- Andrea Surcinelli (ORCID: https://orcid.org/0000-0003-3779-0934)
- Chao Zhu (ORCID: https://orcid.org/0000-0003-3951-7501)
- Masoud Etemadifar (ORCID: https://orcid.org/0000-0003-3318-7513)
- Bassem Yamout
- Magdolna Simó (ORCID: https://orcid.org/0000-0002-1652-2407)
- Jeanette Lechner Scott
Institutions
- Semmelweis University (HU)
- Isfahan University of Medical Sciences (IR)
- Abu Dhabi University (AE)
- The Royal Melbourne Hospital (AU)
- Izmir University (TR)
- University of Debrecen (HU)
- Koç University (TR)
- University of Liverpool (GB)
- University of Antwerp (BE)
- İzmir University of Economics (TR)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Charles University (CZ)
- University of L'Aquila (IT)
- Islamic Azad University, Isfahan (IR)
- Royal Brisbane and Women's Hospital (AU)
- John Hunter Hospital (AU)
- Ghent University Hospital (BE)
- Walton Centre (GB)
- Royal Hobart Hospital (AU)
- Amiri Hospital (KW)
- University of Catania (IT)
- Bakırköy Psychiatric Hospital (TR)
- Hunter Medical Research Institute (AU)
- BioCruces Health research Institute (ES)
- Ospedale "Santa Maria delle Croci" di Ravenna (IT)
- Antwerp University Hospital (BE)
- American University of Beirut Medical Center (LB)
- Hospital de Galdakao (ES)
- Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR)
- Universitair Ziekenhuis Brussel (BE)
- Policlinico Universitario di Catania (IT)
- Sultan Qaboos University Hospital (OM)
- Hunter New England Local Health District (AU)
- Alfred Health (AU)
- Sultan Qaboos University (OM)
- Monash University (AU)
- American University of Beirut (LB)
Publication Details
- Journal
- Journal of Neurology Neurosurgery & Psychiatry
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1136/jnnp-2024-334090
- Citations
- 11
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.67